Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
Biography and Research Information
OverviewAI-generated summary
Katie Pierce's research has focused on infectious diseases, including work on Coxiella burnetii, the causative agent of Q fever. Her publications include investigations into the in vivo development of macrolide resistance in Campylobacter jejuni and the design of questionnaires for retrospective studies. Pierce also has research interests in the immune response to pathogens, with a publication on the metabolic contributions of alveolar macrophages to trained immunity against Mycobacterium tuberculosis. Her scholarly output includes a 2026 publication on phase variation in Coxiella burnetii lipopolysaccharide and a 2010 study on the safety and immunogenicity of a typhoid vaccine. Pierce has collaborated with researchers at the University of Arkansas for Medical Sciences, including Daniel E. Voth, Lin‐Xi Li, J. Tucker Andrews, and Fischer Huey.
Metrics
- h-index: 1
- Publications: 1
- Citations: 1
Positions
-
Pre-doctoral Fellow 2024–presentNIH/NIAID/DIR Laboratory of Bacteriology-Bacterial Immunology and Pathogenesis Unit ORCID
-
Phd Candidate 2022–presentUniversity of Arkansas for Medical Sciences Department of Microbiology and Immunology ORCID
-
Graduate Research/Teaching Assistant 2020–2022Louisiana Tech University Biology ORCID
-
Lead QC Lab Technician 2019–2020Vivolac Cultures Corp Quality Control ORCID
Selected Publications
-
What goes around comes around: updates in the study of Coxiella burnetii lipopolysaccharide phase variation (2026)
-
Coxiella burnetii Nine Mile II Δ cbu0533 as a suitable laboratory replacement strain (2025)
-
Control of human Q fever by vaccination: the journey to Q-VAX and beyond (2025)
-
Metabolism and ontogeny of alveolar macrophages contribute to peripheral trained immunity and confer protection against Mycobacterium tuberculosis (2023)
Collaboration Network
Top Collaborators
Carrie Mae Long
National Institutes of Health (US)
3 shared publications
- Coxiella burnetii Nine Mile II Δ cbu0533 as a suitable laboratory replacement strain
- Control of human Q fever by vaccination: the journey to Q-VAX and beyond
- What goes around comes around: updates in the study of Coxiella burnetii lipopolysaccharide phase variation
Daniel E. Voth
University of Arkansas for Medical Sciences
2 shared publications
In database
- Coxiella burnetii Nine Mile II Δ cbu0533 as a suitable laboratory replacement strain
- Control of human Q fever by vaccination: the journey to Q-VAX and beyond
James Tucker Andrews
University of Arkansas for Medical Sciences
1 shared publication
In database
- Metabolism and ontogeny of alveolar macrophages contribute to peripheral trained immunity and confer protection against Mycobacterium tuberculosis
Miguel Ángel Mercado
University of Arkansas for Medical Sciences (US)
1 shared publication
- Metabolism and ontogeny of alveolar macrophages contribute to peripheral trained immunity and confer protection against Mycobacterium tuberculosis
Fischer Huey
University of Arkansas for Medical Sciences
1 shared publication
In database
- Metabolism and ontogeny of alveolar macrophages contribute to peripheral trained immunity and confer protection against Mycobacterium tuberculosis
Yasir H. Ahmed-Braimah
Syracuse University (US)
1 shared publication
- Metabolism and ontogeny of alveolar macrophages contribute to peripheral trained immunity and confer protection against Mycobacterium tuberculosis
Lin‐Xi Li
University of Arkansas for Medical Sciences
1 shared publication
In database
- Metabolism and ontogeny of alveolar macrophages contribute to peripheral trained immunity and confer protection against Mycobacterium tuberculosis
Lu Huang
University of Arkansas for Medical Sciences
1 shared publication
In database
- Metabolism and ontogeny of alveolar macrophages contribute to peripheral trained immunity and confer protection against Mycobacterium tuberculosis
Robert A. Heinzen
National Institutes of Health (US)
1 shared publication
- Control of human Q fever by vaccination: the journey to Q-VAX and beyond
John Stenos
Barwon Health (AU)
1 shared publication
- Control of human Q fever by vaccination: the journey to Q-VAX and beyond
Stephen Graves
Barwon Health (AU)
1 shared publication
- Control of human Q fever by vaccination: the journey to Q-VAX and beyond
Catharine S. Frederick
National Institute of Allergy and Infectious Diseases (US)
1 shared publication
- Coxiella burnetii Nine Mile II Δ cbu0533 as a suitable laboratory replacement strain
Rebecca Anderson
Office of Research Services (US)
1 shared publication
- What goes around comes around: updates in the study of Coxiella burnetii lipopolysaccharide phase variation
Megan Brose
Office of Research Services (US)
1 shared publication
- What goes around comes around: updates in the study of Coxiella burnetii lipopolysaccharide phase variation
Jessica McCormick-Ell
Office of Research Services (US)
1 shared publication
- What goes around comes around: updates in the study of Coxiella burnetii lipopolysaccharide phase variation
Similar Researchers
Based on overlapping research topics
James Andrews
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation
Betty L. Everett
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation
Bernabe Mercado
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation
Miguel A. B. Mercado
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation
Kara A. O’Neal
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation
Susie L. Brown
University of Arkansas for Medical Sciences
Host-Pathogen Interactions
Microbial infections and disease research
Immune Response and Inflammation